Ovarian Cancer SPORE Career Enhancement Program
The RPCI-UPCI Ovarian Cancer Specialized Programs of Research Excellence (SPORE) supports four Individual Research Projects, four Cores, a Career Enhancement Program (CEP) and a Developmental Research Program (DRP).
The SPORE grant mechanism is aimed at translational research projects. The NIH definition of what constitutes translational research for SPORE applications is:
Translational cancer research transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical applications that reduce cancer incidence, morbidity, and mortality.
The goal of the CEP is to recruit and support new independent investigators in the field of translational ovarian cancer research. Research initiatives that will be funded by the CEP are expected to have a major translational component, including those with an emphasis on etiology, diagnosis, early detection, treatment, or population science. Outstanding entry-level scientific and clinical faculty (i.e. Assistant Professor) are invited to apply. In some instances, CEP awardees may include senior postdoctoral fellows or clinical fellows transitioning to faculty positions and deemed to have high potential to develop independent research programs. The CEP aims to promote diversity within ovarian cancer researchers by encouraging applications from qualified individuals from traditionally underrepresented groups.
- Full-time Faculty Member at RPCI, UPCI, or University of Pittsburgh, Assistant Professor who hold NIH New Investigator status (no record of R01 or R01-type funding)
- Senior postdoctoral or clinical fellows who intend to dedicate their early career to ovarian cancer research and who will transition to a faculty position by the start of funding
Women and minorities are strongly encouraged to apply for a CEP award.
The CEP will fund two to three awards of up to $40,000 per year for two years. Second year funding is contingent on acceptable progress of the project, as documented in a progress report. Successful applicants are required to submit a final progress report at the end of the funding period. Funds cannot be used for salary coverage of Principal or Co-Investigators, indirect costs, travel, publications, or equipment not specifically needed for the proposed research. Salary coverage for technicians, graduate students, or postdoctoral fellows is permitted.
Successful applicants will be required to attend and occasionally present their ongoing work at monthly RPCI-UPCI Ovarian Cancer SPORE meetings, the RPCI-UPCI Ovarian Cancer SPORE annual retreat, and appropriate meetings for their respective home institutions (RPCI: GYN DSRG Meeting; UPCI: Gynecological Oncology Work in Progress meetings).
For scientific questions, please contact the CDP Principal Investigator at your institution:
RPCI: Dr. Kirsten Moysich (email@example.com)
UPCI: Dr. Francesmary Modugno (firstname.lastname@example.org)
For administrative questions, please contact Dr. Amit Lugade (email@example.com)
Pre-proposals: Prospective applicants are required to submit a non-binding, pre-proposal due Monday, April 17, 2017 at 5:00 pm. Pre-proposals should include the Scientific Abstract, Translational Potential, and Specific Aims.
The pre-proposal is used for reviewer assignment. Therefore, specific aims, abstract and translational potential should not be significantly modified once submitted for the pre-proposal.
Full proposals including all documents listed below are due Monday, May 1, 2017 at 5:00 pm.